DJIA 17,156.85 24.88 0.15%
NASDAQ 4,562.19 9.43 0.21%
S&P 500 2,001.57 2.59 0.13%
market minute promo

Sanofi (ADR) (NYSE: SNY)



company name or ticker
Company Photos
(Click to zoom)

Sanofi: Stiff Competition Will Impact Future Performance

Al Mann Trounces The Afrezza Bear Case In Interview With Noted Diabetes Educator

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away

Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada - Analyst Blog

New Lifetime High Reached By Sanofi (SNY)

MannKind In Turmoil: Is It Time To Buy Or Sell?

Eli Lilly/Boehringer's Insulin Biosimilar Gains EU Approval - Analyst Blog

MannKind: Nothing But Good News, Trading Volume Drops, Short Interest Remains Sky High

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks are an important part of a well-rounded portfolio. Yet some high-yielding stocks are better left alone. Here is a look at one top name in healthcare that investors should avoid for the time being.

Peregrine Pharmaceuticals' Q1 Loss Wider than Expected - Analyst Blog

See More Articles...